348 related articles for article (PubMed ID: 218537)
21. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
[TBL] [Abstract][Full Text] [Related]
22. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
23. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
Ihara H; Miyachi M; Imafuku S
J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
[TBL] [Abstract][Full Text] [Related]
24. Varicella vaccine: the American experience.
Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
[TBL] [Abstract][Full Text] [Related]
25. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.
Gershon AA; Steinberg SP; Borkowsky W; Lennette D; Lennette E
Pediatr Infect Dis; 1982; 1(3):164-7. PubMed ID: 6292875
[TBL] [Abstract][Full Text] [Related]
26. Varicella vaccine in children with chronic renal insufficiency.
Broyer M; Boudailliez B
Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
[TBL] [Abstract][Full Text] [Related]
27. Preparation of varicella-herpes zoster immunoglobulin.
Janot C; Stoltz JF; Avenard G; Perrier P; Schooneman F; Streiff F
Transfusion; 1981; 21(6):732-4. PubMed ID: 6274067
[TBL] [Abstract][Full Text] [Related]
28. Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster.
Miyachi M; Ihara H; Imafuku S
J Dermatol; 2017 Jun; 44(6):656-659. PubMed ID: 28012212
[TBL] [Abstract][Full Text] [Related]
29. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
[TBL] [Abstract][Full Text] [Related]
30. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.
Gershon AA; LaRussa P; Steinberg S; Mervish N; Lo SH; Meier P
J Infect Dis; 1996 Feb; 173(2):450-3. PubMed ID: 8568309
[TBL] [Abstract][Full Text] [Related]
31. Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.
Schmidt NJ; Dennis J; Lennette EH
Infect Immun; 1977 Mar; 15(3):850-4. PubMed ID: 192677
[TBL] [Abstract][Full Text] [Related]
32. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients.
Asano Y; Itakura N; Hiroishi Y; Hirose S; Ozaki T; Kuno K; Nagai T; Yazaki T; Yamanishi K; Takahashi M
J Infect Dis; 1985 Nov; 152(5):863-8. PubMed ID: 2995510
[TBL] [Abstract][Full Text] [Related]
33. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.
Brunell PA; Gershon AA; Uduman SA; Steinberg S
J Infect Dis; 1975 Jul; 132(1):49-54. PubMed ID: 169308
[TBL] [Abstract][Full Text] [Related]
34. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
35. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
[TBL] [Abstract][Full Text] [Related]
37. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
[TBL] [Abstract][Full Text] [Related]
38. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
Gallo D; Schmidt NJ
J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
[TBL] [Abstract][Full Text] [Related]
39. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
[TBL] [Abstract][Full Text] [Related]
40. Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus.
Shigeta S; Baba M; Ogata M; Iijima S; Murai C
Microbiol Immunol; 1981; 25(3):295-303. PubMed ID: 6166838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
